Literature DB >> 6302140

Solid renal mass in the cancer patient: second primary renal cell carcinoma versus renal metastasis.

J J Pagani.   

Abstract

Most renal metastases are asymptomatic, occur with widespread metastatic disease, and are too small to be detected with computed tomography (CT). Rarely they form large masses. These are typically angiographically hypovascular and show only minimal CT contrast enhancement. Renal carcinoma as a second primary malignancy in the cancer patient is 4.5 times more common than mass-like renal metastases and demonstrates two CT contrast enhancement patterns. The latter include either minimal enhancement or irregular regions of intense enhancement. These CT contrast enhancement patterns of both renal carcinoma and metastasis can be used to direct the further diagnostic evaluation of these masses and distinguish between a renal metastasis or a second primary renal carcinoma in the cancer patient.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6302140     DOI: 10.1097/00004728-198306000-00011

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  3 in total

1.  Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre.

Authors:  Cathy Zhou; Diana L Urbauer; Bryan M Fellman; Pheroze Tamboli; Miao Zhang; Surena F Matin; Christopher G Wood; Jose A Karam
Journal:  BJU Int       Date:  2015-07-05       Impact factor: 5.588

2.  Imaging appearance of a singular metastatic adenoid cystic carcinoma of the right kidney: A case report and literature review.

Authors:  DA-Sheng Qiu; Li-Ying Xu; Xiao-Yan Hu
Journal:  Oncol Lett       Date:  2014-09-17       Impact factor: 2.967

3.  Second Primary Renal Cell Carcinoma With Nonrenal Malignancies: An Analysis of 118 Cases and a Review of Literature.

Authors:  Jinchao Chen; Nienie Qi; Hua Wang; Zongping Wang; Yedie He; Shaoxing Zhu
Journal:  Front Oncol       Date:  2021-11-25       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.